Repare Therapeutics Inc (RPTX)

Mar 11, 2025

HC Wainwright Issues Pessimistic Forecast for Repare Therapeutics (NASDAQ:RPTX) Stock Price - MarketBeat

Mar 11, 2025

Mar 11, 2025

What Makes Repare Therapeutics (RPTX) a New Buy Stock - Yahoo Finance

Mar 11, 2025

Mar 07, 2025

New Hires at Repare Get Stock Options as Share Price Shows 67% Drop - StockTitan

Mar 07, 2025

Mar 07, 2025

Layoff Tracker: Atea Pharmaceuticals Cuts 25% of Workforce - BioSpace

Mar 07, 2025

Mar 07, 2025

Repare Therapeutics stock target cut to $5 at H.C. Wainwright - Investing.com India

Mar 07, 2025

Mar 07, 2025

Repare Therapeutics stock target cut to $5 at H.C. Wainwright By Investing.com - Investing.com Canada

Mar 07, 2025

Mar 07, 2025

Strategic Pipeline Focus and Financial Stability Support Buy Rating for Repare Therapeutics - TipRanks

Mar 07, 2025

Mar 07, 2025

symbol__ Stock Quote Price and Forecast - CNN

Mar 07, 2025

Mar 07, 2025

Repare Therapeutics (NASDAQ:RPTX) Announces Quarterly Earnings Results, Beats Estimates By $0.10 EPS - MarketBeat

Mar 07, 2025

Mar 04, 2025

Here's Why We're Watching Repare Therapeutics' (NASDAQ:RPTX) Cash Burn Situation - Yahoo Finance

Mar 04, 2025

Mar 03, 2025

Repare Therapeutics Focuses on Clinical Trials Amid Restructuring - TipRanks

Mar 03, 2025

Mar 03, 2025

Repare Therapeutics Restructures and Focuses on Key Clinical Trials - MSN

Mar 03, 2025

Mar 03, 2025

Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results - CRISPR Medicine News

Mar 03, 2025

Mar 03, 2025

Repare Therapeutics anticipates key trial results by late 2025 - Investing.com Canada

Mar 03, 2025

Mar 03, 2025

Repare Therapeutics Inc. SEC 10-K Report - TradingView

Mar 03, 2025

Mar 03, 2025

Repare Therapeutics reports Q4 EPS (67c), consensus (79c) - TipRanks

Mar 03, 2025

Mar 03, 2025

Can Repare Therapeutics' Massive 75% Staff Cut Save Its Clinical Pipeline? - StockTitan

Mar 03, 2025

Mar 02, 2025

Repare Therapeutics Inc. (NASDAQ:RPTX) Shares Sold by ARK Investment Management LLC - MarketBeat

Mar 02, 2025

Feb 28, 2025

Repare Therapeutics stock hits 52-week low at $1.06 By Investing.com - Investing.com South Africa

Feb 28, 2025

Feb 27, 2025

Repare Therapeutics stock hits 52-week low at $1.06 - Investing.com

Feb 27, 2025

Feb 27, 2025

Repare Therapeutics cuts 75% of workforce - MSN

Feb 27, 2025

Feb 26, 2025

Repare Therapeutics to cut 75% of workforce in major restructuring - The Pharma Letter

Feb 26, 2025

Feb 26, 2025

Parp Inhibitor Market Future Business Opportunities 2025-2032 - openPR

Feb 26, 2025

Feb 25, 2025

Repare Therapeutics to cut staff again, this time by 75% - PharmaLive

Feb 25, 2025

Feb 25, 2025

Cambridge-Montreal biotech lets go 75% of employees - The Business Journals

Feb 25, 2025

Feb 25, 2025

Repare Therapeutics Chief Medical Officer to Leave -February 25, 2025 at 01:10 pm EST - Marketscreener.com

Feb 25, 2025

Feb 25, 2025

Repare Therapeutics Announces Major Reorganization in 2025 - TipRanks

Feb 25, 2025

Feb 23, 2025

Repare Therapeutics Inc. (NASDAQ:RPTX) Stock Holdings Lifted by Vontobel Holding Ltd. - Defense World

Feb 23, 2025

Feb 22, 2025

Repare Therapeutics (RPTX) to Release Earnings on Wednesday - MarketBeat

Feb 22, 2025

Feb 20, 2025

Repare Therapeutics Inc. (RPTX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Feb 20, 2025

Feb 20, 2025

Repare Therapeutics Stock Hits 52-Week Low at $1.2 Amid Market Challenges - MSN

Feb 20, 2025

Feb 19, 2025

Repare Therapeutics (RPTX) Expected to Announce Quarterly Earnings on Wednesday - Defense World

Feb 19, 2025

Feb 17, 2025

What Are You Thinking About Investing In Repare Therapeutics Inc (NASDAQ: RPTX) Stock? - Stocks Register

Feb 17, 2025